Comparison of the effect of uric acid/albumin ratio on coronary slow flow with other inflammation-based markers

Toprak K., Özen K., Memioğlu T., Inanır M., KAPLANGÖRAY M., Akyol S., ...Daha Fazla

Biomarkers in Medicine, cilt.18, sa.1, ss.25-37, 2024 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 1
  • Basım Tarihi: 2024
  • Doi Numarası: 10.2217/bmm-2023-0386
  • Dergi Adı: Biomarkers in Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.25-37
  • Anahtar Kelimeler: coronary slow flow, inflammation-based markers, uric acid/albumin ratio
  • Bilecik Şeyh Edebali Üniversitesi Adresli: Evet

Özet

Background: Many inflammation-based markers (IBMs) have been shown to be closely related to coronary slow flow (CSF), but the effect of the uric acid/albumin ratio (UAR) on CSF and its relationship with other IBMs are not clearly known. In this study, we aimed to compare the effects of UAR and other IBMs on CSF. Methods: After the exclusion criteria, 126 patients with CSF detected on coronary angiography and 126 subjects with normal coronary flow as the control group were included in the study. Results: UAR was determined as an independent predictor for CSF. In addition, the UAR was superior to other IBMs in detecting CSF (p < 0.05 for all). Conclusion: This study is the first to investigate the effect of UAR on CSF in comparison with other IBMs.